S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
NYSE:NUS

Nu Skin Enterprises (NUS) Stock Price, News & Analysis

$13.76
+0.92 (+7.17%)
(As of 03/27/2024 ET)
Today's Range
$12.95
$13.76
50-Day Range
$12.29
$18.97
52-Week Range
$12.06
$41.50
Volume
622,443 shs
Average Volume
914,745 shs
Market Capitalization
$679.77 million
P/E Ratio
76.42
Dividend Yield
1.74%
Price Target
$23.67

Nu Skin Enterprises MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
72.1% Upside
$23.67 Price Target
Short Interest
Healthy
4.48% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-2.56
Upright™ Environmental Score
News Sentiment
0.99mentions of Nu Skin Enterprises in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$86,660 Sold Last Quarter
Proj. Earnings Growth
31.86%
From $1.13 to $1.49 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.73 out of 5 stars

Consumer Staples Sector

7th out of 130 stocks

Drugs, Proprietaries, & Sundries Industry

3rd out of 6 stocks

NUS stock logo

About Nu Skin Enterprises Stock (NYSE:NUS)

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

NUS Stock Price History

NUS Stock News Headlines

High-Yield Dividend Stocks to Avoid: 3 Dangerous Picks
The Small Biotech with a BIG Cancer Solution
There's a new cancer treatment so precise, it's been called a "smart bomb." One that can deliver a toxic payload directly to tumors while bypassing healthy cells.
Nu Skin Enterprises Inc Class A NUS
This consistently signaled gains of 453%... 610%... and even 1036%...
It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.
Nu Skin Enterprises Inc. Cl A
Why Nu Skin Enterprises Stock Plunged Today
Q4 2023 NU Skin Enterprises Inc Earnings Call
Nu Skin (NUS) Q4 Earnings Report Preview: What To Look For
See More Headlines
Receive NUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nu Skin Enterprises and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/14/2024
Ex-Dividend for 3/6 Dividend
2/23/2024
Dividend Payable
3/06/2024
Today
3/27/2024
Next Earnings (Estimated)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Drugs, proprietaries, & sundries
Sub-Industry
Personal Products
CUSIP
67018T10
Employees
3,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$23.67
High Stock Price Target
$27.00
Low Stock Price Target
$21.00
Potential Upside/Downside
+72.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$8.60 million
Pretax Margin
1.35%

Debt

Sales & Book Value

Annual Sales
$1.97 billion
Cash Flow
$3.62 per share
Book Value
$16.60 per share

Miscellaneous

Free Float
48,037,000
Market Cap
$679.77 million
Optionable
Optionable
Beta
1.09
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. Steven J. Lund (Age 71)
    Executive Chairman of the Board
    Comp: $659.21k
  • Mr. Ryan S. Napierski (Age 50)
    President, CEO & Director
    Comp: $1.28M
  • Dr. Joseph Y. Chang Ph.D. (Age 71)
    Executive VP & Chief Scientific Officer
    Comp: $907.04k
  • Mr. Chayce David Clark (Age 41)
    Executive VP & General Counsel
    Comp: $593.66k
  • Ms. Mang Yee Tang (Age 53)
    Strategic Advisor
    Comp: $769.56k
  • Mr. Blake M. Roney (Age 65)
    Founder
    Comp: $621.69k
  • Ms. Sandra N. Tillotson (Age 67)
    Founder
    Comp: $1.06M
  • Mr. James D. Thomas (Age 44)
    Executive VP, Chief Accounting Officer & CFO
  • Mr. Joe Sueper
    Senior VP & CTO
  • Mr. Mark L. Adams (Age 72)
    Chief Information Officer

NUS Stock Analysis - Frequently Asked Questions

Should I buy or sell Nu Skin Enterprises stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last year. There are currently 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NUS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NUS, but not buy additional shares or sell existing shares.
View NUS analyst ratings
or view top-rated stocks.

What is Nu Skin Enterprises' stock price target for 2024?

3 brokerages have issued 1-year price objectives for Nu Skin Enterprises' stock. Their NUS share price targets range from $21.00 to $27.00. On average, they anticipate the company's share price to reach $23.67 in the next year. This suggests a possible upside of 72.1% from the stock's current price.
View analysts price targets for NUS
or view top-rated stocks among Wall Street analysts.

How have NUS shares performed in 2024?

Nu Skin Enterprises' stock was trading at $19.42 at the beginning of 2024. Since then, NUS stock has decreased by 29.2% and is now trading at $13.7550.
View the best growth stocks for 2024 here
.

Are investors shorting Nu Skin Enterprises?

Nu Skin Enterprises saw a decline in short interest in February. As of February 29th, there was short interest totaling 2,040,000 shares, a decline of 17.7% from the February 14th total of 2,480,000 shares. Based on an average daily volume of 779,500 shares, the days-to-cover ratio is presently 2.6 days. Currently, 4.2% of the shares of the stock are sold short.
View Nu Skin Enterprises' Short Interest
.

When is Nu Skin Enterprises' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our NUS earnings forecast
.

How were Nu Skin Enterprises' earnings last quarter?

Nu Skin Enterprises, Inc. (NYSE:NUS) released its earnings results on Wednesday, February, 14th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.08. The company had revenue of $488.64 million for the quarter, compared to analyst estimates of $479.35 million. Nu Skin Enterprises had a trailing twelve-month return on equity of 10.73% and a net margin of 0.44%.

How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?

Nu Skin Enterprises announced a quarterly dividend on Wednesday, February 14th. Stockholders of record on Monday, February 26th will be given a dividend of $0.06 per share on Wednesday, March 6th. This represents a $0.24 annualized dividend and a yield of 1.74%. The ex-dividend date of this dividend is Friday, February 23rd.
Read our dividend analysis for NUS
.

Is Nu Skin Enterprises a good dividend stock?

Nu Skin Enterprises (NYSE:NUS) pays an annual dividend of $0.24 per share and currently has a dividend yield of 1.92%. The dividend payout ratio is 133.34%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, NUS will have a dividend payout ratio of 16.11% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for NUS.

What guidance has Nu Skin Enterprises issued on next quarter's earnings?

Nu Skin Enterprises issued an update on its first quarter 2024 earnings guidance on Wednesday, February, 14th. The company provided earnings per share guidance of 0.000-0.100 for the period, compared to the consensus EPS estimate of 0.340. The company issued revenue guidance of $400.0 million-$435.0 million, compared to the consensus revenue estimate of $479.7 million.

What is Ritch Wood's approval rating as Nu Skin Enterprises' CEO?

72 employees have rated Nu Skin Enterprises Chief Executive Officer Ritch Wood on Glassdoor.com. Ritch Wood has an approval rating of 91% among the company's employees. This puts Ritch Wood in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Nu Skin Enterprises own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), NVIDIA (NVDA), Marathon Petroleum (MPC), Gilead Sciences (GILD), Alphabet (GOOG), Tesla (TSLA), Herbalife (HLF), Mastercard (MA) and Netflix (NFLX).

Who are Nu Skin Enterprises' major shareholders?

Nu Skin Enterprises' stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (12.58%), Vanguard Group Inc. (12.58%), Dimensional Fund Advisors LP (2.82%), Charles Schwab Investment Management Inc. (2.34%), Northern Trust Corp (1.12%) and Voloridge Investment Management LLC (1.00%). Insiders that own company stock include Andrew D Lipman, D Matthew Dorny, Edwina D Woodbury, Emma S Battle, James D Thomas, Jeffrey Clark Bettinger, Joseph Y Chang, Laura Nathanson, Mark H Lawrence, Ritch N Wood, Ryan S Napierski, Steven Keith Hatchett and Steven Lund.
View institutional ownership trends
.

How do I buy shares of Nu Skin Enterprises?

Shares of NUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:NUS) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners